Venetoclax plus hypomethylating agents as effective bridge therapy to allogeneic stem cell transplant in relapsed/refractory acute myeloid leukaemia: A subanalysis of the AVALON study

ABSTRACT:

SUBMITTER: Petracci E 

PROVIDER: S-EPMC12916181 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature